SCSamuel P. Carmichael

Samuel P. Carmichael

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Samuel P. Carmichael has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher P. Michetti

    Department of Surgery, Inova Fairfax Hospital, Falls Church, Virginia, USA

    4 shared publications
  • David M. Kline

    From the Department of Surgery (S.P.C.), Institute for Regenerative Medicine (S.P.C., P.K.C., J.W.V., A.A.), and Division of Public Health Sciences, Department of Biostatistics and Data Science (D.M.K.), Wake Forest School of Medicine, Winston-Salem, North Carolina; and Department of Surgery (J.B.H.), University of Alabama at Birmingham School of Medicine, Birmingham, Alabama

    4 shared publications
  • John B. Holcomb

    From the Department of Surgery (S.P.C.), Institute for Regenerative Medicine (S.P.C., P.K.C., J.W.V., A.A.), and Division of Public Health Sciences, Department of Biostatistics and Data Science (D.M.K.), Wake Forest School of Medicine, Winston-Salem, North Carolina; and Department of Surgery (J.B.H.), University of Alabama at Birmingham School of Medicine, Birmingham, Alabama

    4 shared publications
  • John W. Vaughan

    From the Department of Surgery (S.P.C.), Institute for Regenerative Medicine (S.P.C., P.K.C., J.W.V., A.A.), and Division of Public Health Sciences, Department of Biostatistics and Data Science (D.M.K.), Wake Forest School of Medicine, Winston-Salem, North Carolina; and Department of Surgery (J.B.H.), University of Alabama at Birmingham School of Medicine, Birmingham, Alabama

    4 shared publications
  • Prafulla K. Chandra

    From the Department of Surgery (S.P.C.), Institute for Regenerative Medicine (S.P.C., P.K.C., J.W.V., A.A.), and Division of Public Health Sciences, Department of Biostatistics and Data Science (D.M.K.), Wake Forest School of Medicine, Winston-Salem, North Carolina; and Department of Surgery (J.B.H.), University of Alabama at Birmingham School of Medicine, Birmingham, Alabama

    4 shared publications
  • Lisa Kodadek

    Surgery, Yale University School of Medicine, New Haven, Connecticut, USA

    3 shared publications

Latest Publications

  • Human placental stem cell–based therapies for prevention of abdominal adhesions: A prospective randomized preclinical trial

    by Samuel P. Ii Carmichael, Prafulla K. Chandra, John W. Vaughan, David M. Kline, John B. Holcomb, Anthony Atala

    BACKGROUND: Abdominal adhesions are networks of fibrotic tissues that form between organs postoperatively. Current prophylactic strategies do not reproducibly prevent adhesive small bowel obstruction across the entire abdomen. Human placental-derived stem cells produce an anti-inflammatory secretome that has been applied to multiple fibrosing diseases. The purpose of this project is to test human placental stem cell (hPSC)–based therapies for prevention of abdominal adhesions in a clinically relevant rat model. METHODS: Fifty-four (n = 54, n = 6/group) male Sprague-Dawley rats (250–350 g) underwent model creation and treatment randomization under anesthesia. Experimental groups included human placental-derived stem cells (hPSC, 5 × 106 cells/10 mL Plasmalyte A), human placental-derived stem cells in a hyaluronic acid (HA-Mal-hPSC) hydrogel, the human placental-derived stem cell secretome from conditioned media in 10 mL Plasmalyte A, human placental-derived stem cells' conditioned media in a hyaluronic acid (HA-Mal-CM) hydrogel, Plasmalyte A (media alone, 10 mL), hyaluronic acid hydrogel alone (HA-Mal), Seprafilm (Baxter, Deerfield, IL), and the control groups, model with no treatment (MNT) and sham animals. Treatments were administered intraperitoneally, and the study period was 14 days postoperation. Adhesions were scored at necropsy and analyzed as the difference between means of an index statistic (Animal Index Score) versus MNT. Underlying molecular mechanisms were explored by functional genomic analysis and histology of peritoneal tissues. RESULTS: Hyaluronic acid hydrogel alone, HA-Mal-CM hydrogel, and Seprafilm significantly reduced the overall appearance of abdominal adhesions by mean Animal Index Score at 14 days versus MNT. Human placental stem cell, HA-Mal-hPSC hydrogel, HA-Mal-CM hydrogel, HA-Mal hydrogel alone, and Seprafilm significantly reduced the collagen content of injured peritoneal tissues. Human placental stem cell and HA-Mal-hPSC hydrogel suppressed expression of the most profibrotic genes. Conditioned media, HA-Mal hydrogel alone, and media alone significantly altered the expression of proteins associated with peritoneal fibrotic pathways. CONCLUSION: Human placental stem cell–based therapies reduce abdominal adhesions in a prospective randomized preclinical trial. This effect is supported by suppression of profibrotic genomic and proteomic pathways.


  • A Scoping Review of Animal Models for Development of Abdominal Adhesion Prevention Strategies

    by Samuel P. Carmichael, Prafulla K. Chandra, John W. Vaughan, David M. Kline, Edward H. Ip, John B. Holcomb, Anthony J. Atala


  • Open Access

    Pre-operative Decision Making in Adhesive Small Bowel Obstructions

    by W. T. Hillman Terzian, Samuel P. Carmichael

    Purpose of Review: The goal of this paper was to evaluate contemporary trends in the work-up and management of adhesive small bowel obstructions (ASBOs). The water-soluble contrast challenge (WSCC) has become the standard of care for differentiating non-operative from operative ASBOs, however there is significant variability among institutions regarding the timing of nasogastric decompression before initiating the study as well as the amount of contrast to be used and the length of time that should be allowed to pass before it is decided that a patient has “failed” the WSCC. Recent Findings: The latest findings include evidence that the duration of nasogastric decompression necessary to perform a WSCC may be as short as two hours, however most institutions still practice a longer decompression period. We also present data that suggests that while the original Bologna guidelines suggested a safe window of non-operative management between three and five days for the WSCC to occur, it is possible that those patients who take over eight hours of contrast transit time to pass the WSCC have a higher likelihood of one-year ASBO recurrence and should be considered for operative intervention, even if contrast eventually makes it to their colon. Summary: We offer an evidence-based standardized approach to administering the WSCC.


  • Prevention of post‐operative adhesions: Model development and pilot outcomes of human placental stem cell‐based interventions

    by Samuel P. Carmichael, Prafulla K. Chandra, John W. Vaughan, David M. Kline, Edward H. Ip, John B. Holcomb, Anthony Atala

    Background: Abdominal adhesions are the most common surgical complication and without reliable prophylactics. This study presents a novel rat model for abdominal adhesions and reports pilot results of human placental stem cell (hPSC)‐based therapies.Methods: Forty‐four (n = 44) male Sprague–Dawley rats (250‐350 g) were used in the experiment. Of these, thirty‐eight (n = 38) were included in a preliminary data set to determine a minimum treatment effect. Adhesions were created in a reproducible model to the abdominal wall and between organs. Experimental groups included the control group (Model No Treatment, MNT), Plasmalyte A (Media Alone, MA, 10 mL), hPSC (5 × 106 cells/10 mL Plasmalyte A), hPSC‐CM (hPSC secretome, conditioned media) in 10 mL Plasmalyte A, Seprafilm™ (Baxter, Deerfield, IL), and sham animals (laparotomy only). Treatments were inserted intraperitoneally (IP) and the study period was 14 days post‐operation. Results are reported as the difference between means of an index statistic (AIS, Animal Index Score) and compared by ANOVA with pairwise comparison.Results: The overall mean AIS was 23 (SD 6.16) for the MNT group with an average of 75% of ischemic buttons involved in abdominal adhesions. Treatment groups MA (mean overall AIS 17.33 SD 6.4), hPSC (mean overall AIS 13.86 SD 5.01), hPSC‐CM (mean overall AIS 13.13 SD 6.15), and Seprafilm (mean overall AIS 13.43 SD 9.11) generated effect sizes of 5.67, 9.14, 9.87, and 9.57 decrease in mean overall AIS, respectively, versus the MNT.Discussion: The presented rat model and scoring system represent the clinical adhesion disease process. hPSC‐based interventions significantly reduce abdominal adhesions in this pilot dataset.


  • Open Access

    Penetrating chest trauma from a “less lethal” bean bag in the United States: a case report

    by Gloria Sanin, Gabriel Cambronero, Megan E. Lundy, William T. Terzian, Martin D. Avery, Samuel P. Carmichael Ii, Maggie Bosley

    This case report presents the case of a 49-year-old man who presented to our level I trauma center after sustaining injuries in an altercation with local law enforcement in which he was shot with a less lethal bean bag and tased. In a primary survey, a penetrating left supraclavicular wound was noted in addition to a taser dart lodged in his flank. No other traumatic findings were noted in a secondary survey. Given hemodynamic stability, completion imaging was obtained, revealing a foreign body in the left lung, a left open clavicle fracture, a C5 tubercle fracture, a possible grade I left vertebral injury, and a left first rib fracture. Soft tissue gas was seen around the left subclavian and axillary arteries, although no definitive arterial injury was identified. The bean bag projectile was embedded in the parenchyma of the left lung on cross-sectional imaging. The patient underwent thoracotomy for removal of the projectile and hemostasis. A thoracotomy was chosen as the operative approach due to concerns about significant bleeding upon foreign body removal. A chest tube was placed and subsequently removed on postoperative day 5. The patient was discharged on postoperative day 7. At a 2-week outpatient follow-up visit, the patient was doing well. This case report is the first to describe this outcome for a drag-stabilized bean bag. Although law enforcement officers utilize bean bag projectiles as a “less lethal” means of crowd control and protection, these ballistics pose significant risk and can result in serious injury.

  • Geographic Variation in Operative Management of Adhesive Small Bowel Obstruction

    by Samuel P. Carmichael, David M. Kline, Nathan T. Mowery, Preston R. Miller, J. Wayne Meredith, Amresh D. Hanchate


  • The COST of liver disease: The Cirrhosis Outcomes Score in Trauma Study

    by Rachel D Appelbaum, Katherine M Riera, Madeline R Fram, Gregory B Russell, Samuel P Carmichael Ii, R Shayn Martin, J Jason Hoth, Nathan T Mowery, Andrew M Nunn


  • ENDOTHELIAL GLYCOCALYX SHEDDING IN INTRA-ABDOMINAL SEPSIS: A FEASIBILITY STUDY

    by Samuel P. Carmichael, Rachel D. Appelbaum, Antonio Renaldo, Nathaniel Hauser, Elaheh Rahbar, Andrew M. Nunn

    Background: The endothelial glycocalyx layer (EGL) is a complex meshwork of glycosaminoglycans and proteoglycans that protect the vascular endothelium. Cleavage or shedding of EGL-specific biomarkers, such as hyaluronic acid (HA) and syndecan-1 (SDC-1, CD138) in plasma, have been shown to be associated with poor clinical outcomes. However, it is unclear whether levels of circulating EGL biomarkers are representative of the EGL injury within the tissues. The objective of the present feasibility study was to describe a pathway for plasma and tissue procurement to quantify EGL components in a cohort of surgical patients with intra-abdominal sepsis. We sought to compare differences between tissue and plasma EGL biomarkers and to determine whether EGL shedding within the circulation and/or tissues correlated with clinical outcomes. Methods: This was a prospective, observational, single-center feasibility study of adult patients (N = 15) with intra-abdominal sepsis, conducted under an approved institutional review boards. Blood and resected tissue (pathologic specimen and unaffected peritoneum) samples were collected from consented subjects at the time of operation and 24–48 hours after surgery. Endothelial glycocalyx layer biomarkers (i.e., HA and SDC-1) were quantified in both tissue and plasma samples using a CD138 stain and ELISA kit, respectively. Pairwise comparisons were made between plasma and tissue levels. In addition, we tested the relationships between measured EGL biomarkers and clinical status and patient outcomes. Results: Fifteen patients with intra-abdominal sepsis were enrolled in the study. Elevations in EGL-specific circulating biomarkers (HA, SDC-1) were positively correlated with postoperative SOFA scores and weakly associated with resuscitative volumes at 24 hours. Syndecan-1 levels from resected pathologic tissue significantly correlated with SOFA scores at all time points (R = 0.69 and P < 0.0001) and positively correlated with resuscitation volumes at 24 hours (R = 0.41 and P = 0.15 for t = 24 hours). Tissue and circulating HA and SDC-1 positively correlated with SOFA >6. Conclusions: Elevations in both circulating and tissue EGL biomarkers were positively correlated with postoperative SOFA scores at 24 hours, with resected pathologic tissue EGL levels displaying significant correlations with SOFA scores at all time points. Tissue and circulating EGL biomarkers were positively correlated at higher SOFA scores (SOFA > 6) and could be used as indicators of resuscitative needs within 24 hours of surgery. The present study demonstrates the feasibility of tissue and plasma procurement in the operating room, although larger studies are needed to evaluate the predictive value of these EGL biomarkers for patients with intra-abdominal sepsis.


  • Open Access

    Prevention of alcohol withdrawal syndrome in the surgical ICU: an American Association for the Surgery of Trauma Critical Care Committee Clinical Consensus Document

    by Anupamaa Seshadri, Rachel Appelbaum, Samuel P Carmichael, Michael Steven Farrell, Dina M Filiberto, Randeep Jawa, Lisa Kodadek, Samuel Mandell, M Victoria P Miles, Jasmeet Paul, et al.

    Alcohol withdrawal syndrome is a common and challenging clinical entity present in trauma and surgical intensive care unit (ICU) patients. The screening tools, assessment strategies, and pharmacological methods for preventing alcohol withdrawal have significantly changed during the past 20 years. This Clinical Consensus Document created by the American Association for the Surgery of Trauma Critical Care Committee reviews the best practices for screening, monitoring, and prophylactic treatment of alcohol withdrawal in the surgical ICU.